Profilo
Lori Friedman is currently Director at NextRNA Therapeutics, Inc. since 2023.
Director at Project Scientist since 2018.
Chief Scientific Officer at Oric Pharmaceuticals, Inc. since 2019.
Formerly Independent Director at Jiya Acquisition Corp.
Head-Translational Oncology at Genentech, Inc. Earned a doctorate from the University of California, Berkeley.
Posizioni attive di Lori Friedman
| Società | Posizione | Inizio |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
Project Scientist
Project Scientist Investment Trusts/Mutual FundsMiscellaneous Operates as an education nonprofit organization | Direttore/Membro del Consiglio | 01/05/2018 |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Direttore/Membro del Consiglio | 26/09/2023 |
Precedenti posizioni note di Lori Friedman
| Società | Posizione | Fine |
|---|---|---|
| JIYA ACQUISITION CORP. | Direttore/Membro del Consiglio | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Formazione di Lori Friedman
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Project Scientist
Project Scientist Investment Trusts/Mutual FundsMiscellaneous Operates as an education nonprofit organization | Miscellaneous |
Jiya Acquisition Corp.
Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Health Technology |
















